Cargando…
Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo
Targeted nanoparticles of different origins are considered as new-generation diagnostic and therapeutic tools. However, there are no targeted drug formulations within the composition of nanoparticles approved by the FDA for use in the clinic, which is associated with the insufficient effectiveness o...
Autores principales: | Obozina, Anastasiia S., Komedchikova, Elena N., Kolesnikova, Olga A., Iureva, Anna M., Kovalenko, Vera L., Zavalko, Fedor A., Rozhnikova, Tatiana V., Tereshina, Ekaterina D., Mochalova, Elizaveta N., Shipunova, Victoria O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861179/ https://www.ncbi.nlm.nih.gov/pubmed/36678860 http://dx.doi.org/10.3390/pharmaceutics15010231 |
Ejemplares similares
-
Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo
por: Kovalenko, Vera L., et al.
Publicado: (2022) -
Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents
por: Kovalenko, Vera L., et al.
Publicado: (2023) -
Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells
por: Komedchikova, Elena N., et al.
Publicado: (2022) -
Fluorescent Magnetic Nanoparticles for Bioimaging through Biomimetic Surface Modification
por: Drozdov, Andrey S., et al.
Publicado: (2022) -
Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy
por: Shipunova, Victoria O., et al.
Publicado: (2023)